NO980929L - Nye benzoksazindionderivater, fremgangsmÕte for deres fremstilling og deres anvendelse - Google Patents

Nye benzoksazindionderivater, fremgangsmÕte for deres fremstilling og deres anvendelse

Info

Publication number
NO980929L
NO980929L NO980929A NO980929A NO980929L NO 980929 L NO980929 L NO 980929L NO 980929 A NO980929 A NO 980929A NO 980929 A NO980929 A NO 980929A NO 980929 L NO980929 L NO 980929L
Authority
NO
Norway
Prior art keywords
processes
preparation
dione derivatives
benzoxazine dione
new
Prior art date
Application number
NO980929A
Other languages
English (en)
Other versions
NO310657B1 (no
NO980929D0 (no
Inventor
Lothar Heinisch
Steffen Wittmann
Llmann Ute M
Rolf Reissbrodt
Original Assignee
Gr Nenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gr Nenthal Gmbh filed Critical Gr Nenthal Gmbh
Publication of NO980929D0 publication Critical patent/NO980929D0/no
Publication of NO980929L publication Critical patent/NO980929L/no
Publication of NO310657B1 publication Critical patent/NO310657B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NO19980929A 1997-03-05 1998-03-04 Nye benzoksazindionderivater og deres anvendelse NO310657B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19708846A DE19708846A1 (de) 1997-03-05 1997-03-05 Neue Benzoxazindionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (3)

Publication Number Publication Date
NO980929D0 NO980929D0 (no) 1998-03-04
NO980929L true NO980929L (no) 1998-09-07
NO310657B1 NO310657B1 (no) 2001-08-06

Family

ID=7822233

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19980929A NO310657B1 (no) 1997-03-05 1998-03-04 Nye benzoksazindionderivater og deres anvendelse

Country Status (29)

Country Link
US (1) US6013647A (no)
EP (1) EP0863139B1 (no)
JP (1) JPH10316666A (no)
KR (1) KR19980079905A (no)
CN (1) CN1075064C (no)
AR (1) AR010125A1 (no)
AT (1) ATE200080T1 (no)
AU (1) AU737760B2 (no)
BR (1) BR9802894A (no)
CA (1) CA2230965A1 (no)
CO (1) CO4950613A1 (no)
CZ (1) CZ65098A3 (no)
DE (2) DE19708846A1 (no)
DK (1) DK0863139T3 (no)
ES (1) ES2157617T3 (no)
GR (1) GR3035834T3 (no)
HU (1) HUP9800472A3 (no)
IL (1) IL123535A (no)
NO (1) NO310657B1 (no)
NZ (1) NZ329883A (no)
PE (1) PE71799A1 (no)
PL (1) PL325142A1 (no)
PT (1) PT863139E (no)
RU (1) RU2184114C2 (no)
SI (1) SI0863139T1 (no)
SK (1) SK28898A3 (no)
UA (1) UA45414C2 (no)
UY (1) UY24915A1 (no)
ZA (1) ZA981847B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6115157A (en) * 1997-12-24 2000-09-05 Nortel Networks Corporation Methods for equalizing WDM systems
US6509334B1 (en) * 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
DE10111164A1 (de) * 2001-03-01 2002-09-05 Gruenenthal Gmbh Neue substituierte Catecholderivate abgeleitet von mehrbasischen sekundären Aminosäuren, Verfahren zu ihrer Herstellung und ihre Anwendung
US7595073B2 (en) * 2003-02-28 2009-09-29 Kraft Foods Global Brands Llc Use of siderophores and organic acids to retard lipid oxidation
US20040186087A1 (en) * 2003-03-20 2004-09-23 Ceramoptec Industries, Inc. Siderophore conjugates of photoactive dyes for photodynamic therapy
EP1888574B1 (en) 2005-05-25 2009-09-02 Actelion Pharmaceuticals Ltd. New antibiotic derivatives
TWI603962B (zh) 2016-09-10 2017-11-01 國立清華大學 含硫噁嗪化合物及其合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3047573A (en) * 1962-07-31 N-alkylamido substituted
FR831710A (fr) * 1937-02-02 1938-09-13 Procédé de fabrication de fermetures à tirette, à partir de matière non métallique
GB878603A (en) * 1959-07-01 1961-10-04 Nippon Shinyaku Co Ltd Salicyclic acid derivatives
DE1147583B (de) * 1959-07-01 1963-04-25 Nippon Shinyaku Co Ltd Verfahren zur Herstellung von 2, 4-Dioxo-dihydro-1, 3-benzoxazinyl-(3)-essigsaeure-dialkylamiden
US4338439A (en) * 1976-08-26 1982-07-06 Eli Lilly And Company 7-[2-[(Substituted benzoyl]amino]acetamido]cephalosporins
US4319028A (en) * 1976-08-26 1982-03-09 Eli Lilly And Company 7-(2-(Substituted benzoyl)amino)acetamido)cephalosporins
US4338436A (en) * 1976-08-26 1982-07-06 Eli Lilly And Company 7-[2-[(Substituted benzoyl)amino]acetamido]cephalosporins
US4665070A (en) * 1985-06-25 1987-05-12 Syntex (U.S.A.) Inc. 2-oxy-4H-3,1-benzoxazin-4-ones and pharmaceutical use
GB8811055D0 (en) * 1988-05-10 1988-06-15 Ici Plc Antibiotic compounds
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
DE4102234A1 (de) * 1991-01-23 1992-07-30 Dresden Arzneimittel Neue (alpha)-aminochinolinoyl-(3)-penicilline, verfahren zu deren herstellung und diese enthaltende antibakterielle mittel
IT1256023B (it) * 1992-06-10 1995-11-20 Italfarmaco Spa Derivati benzossazinonici e benzotiazinonici ad attivita' cardiovascolare
DE19654920A1 (de) * 1996-06-26 1998-01-08 Gruenenthal Gmbh Neue synthetische Catecholderivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
HU9800472D0 (en) 1998-04-28
AR010125A1 (es) 2000-05-17
CN1075064C (zh) 2001-11-21
PE71799A1 (es) 1999-08-07
BR9802894A (pt) 2000-03-21
US6013647A (en) 2000-01-11
HUP9800472A2 (hu) 1999-06-28
UY24915A1 (es) 2000-12-29
PL325142A1 (en) 1998-09-14
AU5645598A (en) 1998-09-10
HK1015763A1 (en) 1999-10-22
EP0863139B1 (de) 2001-03-28
GR3035834T3 (en) 2001-08-31
KR19980079905A (ko) 1998-11-25
DK0863139T3 (da) 2001-04-30
UA45414C2 (uk) 2002-04-15
PT863139E (pt) 2001-07-31
IL123535A (en) 2000-10-31
JPH10316666A (ja) 1998-12-02
CN1195664A (zh) 1998-10-14
DE59800568D1 (de) 2001-05-03
ZA981847B (en) 1998-09-08
SK28898A3 (en) 1998-11-04
CA2230965A1 (en) 1998-09-05
CZ65098A3 (cs) 1998-09-16
SI0863139T1 (en) 2001-06-30
IL123535A0 (en) 1998-10-30
NO310657B1 (no) 2001-08-06
ATE200080T1 (de) 2001-04-15
DE19708846A1 (de) 1998-09-17
ES2157617T3 (es) 2001-08-16
CO4950613A1 (es) 2000-09-01
NZ329883A (en) 1999-04-29
RU2184114C2 (ru) 2002-06-27
NO980929D0 (no) 1998-03-04
AU737760B2 (en) 2001-08-30
HUP9800472A3 (en) 2000-09-28
EP0863139A1 (de) 1998-09-09

Similar Documents

Publication Publication Date Title
NO20015113L (no) Nye forbindelser, deres fremstilling og anvendelse
NO980720D0 (no) Pyridazin-3-on-derivater, deres anvendelse og mellomprodukter for deres fremstilling
DK0740668T3 (da) Tetracykliske derivater, fremgangsmåde til deres fremstilling og deres anvendelse
NO954942D0 (no) Nye erytromycinderivater, fremgangsmåte for deres fremstilling og anvendelse av derivatene som legemidler
NO975710D0 (no) Nye Dolastatinderivater, deres fremstilling og anvendelse
NO964654D0 (no) Nye erytromycinderivater, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler
NO954369D0 (no) Oksazolidindionderivater, deres fremstilling og anvendelse
NO991815L (no) Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter
NO20011503D0 (no) Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, deres fremstilling og anvendelse som anorektiske legemidler
NO991761D0 (no) Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse
DK0885234T3 (da) Nye erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
NO20000294L (no) Derivater av acylpiperazinylpyrimidiner, deres fremstilling og anvendelse som legemidler
DK1004592T3 (da) Nye erythromycinderivater, deres fremstilling og deres anvendelse som medikamenter
NO984717D0 (no) Nye hydroksamsyre-derivater, deres fremstilling og anvendelse
DK1043307T3 (da) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO985307L (no) Distamycinderivater, fremgangsmÕte for deres fremstilling, og deres anvende
NO20001934D0 (no) 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse
DK0835254T3 (da) Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse
NO983860D0 (no) Nye triazolopuriner, fremgangsmÕte for fremstilling av dem og deres anvendelse som legemidler
DK0701554T3 (da) Benzisoselen-azolinderivater og -azinderivater, fremgangsmåde til fremstilling heraf og deres terapeutiske anvendelse
DK0782575T3 (da) Substituerede pyrazol-pyrazol-derivater, fremgangsmåde til deres fremsstilling samt deres anvendelse som midler med herbicid virkning
NO980929D0 (no) Nye benzoksazindionderivater, fremgangsmåte for deres fremstilling og deres anvendelse
NO984624D0 (no) Nye furan-diarylmetyliden-derivater, fremgangsmÕte for deres fremstilling og terapeutiske anvendelser derav
NO971424D0 (no) Nye heterocyklisk substituerte imidazolo-kinoksalidoner, deres fremstilling og anvendelse
NO955242D0 (no) Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees